Cargando…

A novel compound heterozygous of β-thalassemia with HbG-Coushatta: case report of Iran

A 30-year-old male couple from Ardabil city, Iran, were admitted for premarital screening. An abnormal band in HbS/D regions with high levels of HbF and HbA 2 led us to suspect the possibility of a compound heterozygous state of β-thalassemia in our affected proband. Therefore, beta globin chain seq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soozangar, Narges, Abbaspour, Ehsan, Mokaber, Haleh, Nematollahi, Zahra, Davarnia, Behzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Data Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185494/ https://www.ncbi.nlm.nih.gov/pubmed/37188672 http://dx.doi.org/10.1038/s41439-023-00243-y

Ejemplares similares

GJB2 mutations in Iranian Azeri population with autosomal recessive nonsyndromic hearing loss (ARNSHL): First report of c.238 C>A mutation in Iran
por: Abbaspour Rodbaneh, Ehsan, et al.
Publicado: (2021)

Association of polymorphisms in the HBG1‐HBD intergenic region with HbF levels
por: Hu, Li, et al.
Publicado: (2020)

The compound state: Hb S/beta-thalassemia()
por: Figueiredo, Maria Stella
Publicado: (2015)

Estimating the age of Hb G‐Coushatta [β22(B4)Glu→Ala] mutation by haplotypes of β‐globin gene cluster in Denizli, Turkey
por: Ozturk, Onur, et al.
Publicado: (2018)

HBG2 -158 (C>T) polymorphism and its contribution to fetal hemoglobin variability in Iraqi Kurds with beta-thalassemia minor
por: Albarawi, Dilan J., et al.
Publicado: (2018)

Utilidad de la cuantificación de la hemoglobina glucosilada (HbG) en el control de pacientes diabéticos
por: Moreno Barrientos, María
Publicado: (1987)

Primary microcephaly caused by novel compound heterozygous mutations in ASPM
por: Okamoto, Nobuhiko, et al.
Publicado: (2018)

A new heterozygous compound mutation in the CTSA gene in galactosialidosis
por: Nakajima, Hideki, et al.
Publicado: (2019)

MCAD deficiency caused by compound heterozygous pathogenic variants in ACADM
por: Nohara, Fumikatsu, et al.
Publicado: (2022)

Normal early development in siblings with novel compound heterozygous variants in ASPM
por: Moriwaki, Taro, et al.
Publicado: (2020)

Moyamoya syndrome in a child with HbEβ‐thalassemia
por: Zahra, Akmal, et al.
Publicado: (2022)

MIR29B mediates epigenetic mechanisms of HBG gene activation
por: Starlard‐Davenport, Athena, et al.
Publicado: (2019)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Novel CLCN7 compound heterozygous mutations in intermediate autosomal recessive osteopetrosis
por: Okamoto, Nana, et al.
Publicado: (2017)

Compound heterozygous variants in the ABCG8 gene in a Japanese girl with sitosterolemia
por: Hashimoto, Nobuhiro, et al.
Publicado: (2020)

Heterozygote Hemoglobin G-Coushatta as the Cause of a Falsely Decreased Hemoglobin A1C in an Ion-exchange HPLC Method
por: Kurtoğlu, Ayşegül Uğur, et al.
Publicado: (2017)

Novel compound heterozygous variants in the LARP7 gene in a patient with Alazami syndrome
por: Dateki, Sumito, et al.
Publicado: (2018)

A novel compound heterozygous mutation in TTC8 identified in a Japanese patient
por: Sato, Shigeru, et al.
Publicado: (2019)

The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
por: Hannemann, A., et al.
Publicado: (2011)

Hydroxyurea decreases hospitalizations in pediatric patients with Hb SC and Hb SB+ thalassemia
por: Lebensburger, Jeffrey D, et al.
Publicado: (2015)

Comment on: "Economic Burden of Thalassemia Major in Iran, 2015"
por: Rezaei, Satar, et al.
Publicado: (2016)

Novel compound heterozygous CDH23 variants in a patient with Usher syndrome type I
por: Okano, Satomi, et al.
Publicado: (2019)

Structural and Functional Characterization of a New Double Variant Haemoglobin (HbG-Philadelphia/Duarte α (2) (68Asn→Lys) β (2) (62Ala→Pro))
por: Fais, Antonella, et al.
Publicado: (2011)

Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children
por: Riewpaiboon, Arthorn, et al.
Publicado: (2010)

A novel compound heterozygous variant of ECHS1 identified in a Japanese patient with Leigh syndrome
por: Uchino, Shumpei, et al.
Publicado: (2019)

A pediatric case of hypomagnesemia 1 (HOMG1) caused by novel compound heterozygous mutations in TRPM6
por: Goda, Takeshi, et al.
Publicado: (2019)

β-thalassemia caused by compound heterozygous mutations and cured by bone marrow transplantation: A case report
por: Wu, Liusong, et al.
Publicado: (2017)

Beta Globin Frameworks in Thalassemia Major Patients from North Iran
por: Akhavan-Niaki, Haleh, et al.
Publicado: (2012)

β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain
por: Ropero, Paloma, et al.
Publicado: (2022)

Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option
por: Starlard-Davenport, Athena, et al.
Publicado: (2022)

Biallelic mutations of EGFR in a compound heterozygous state cause ectodermal dysplasia with severe skin defects and gastrointestinal dysfunction
por: Hayashi, Shion, et al.
Publicado: (2018)

The Selenium Status in Thalassemia Patients in South East of Iran
por: Mashhadi, Mohammad Ali, et al.
Publicado: (2014)

Heterozygous HbAC but not HbAS is associated with higher newborn birthweight among women with pregnancy-associated malaria
por: Tétard, Marilou, et al.
Publicado: (2017)

HB E/β°Thalassemia can present with normal phenotype
por: Pal, Ranabir, et al.
Publicado: (2010)

Glutathione Redox System in β-Thalassemia/Hb E Patients
por: Kalpravidh, Ruchaneekorn W., et al.
Publicado: (2013)

Low HbA2 Level in β-Thalassemia Trait
por: ÖZSOYLU, Şinasi
Publicado: (2013)

Mitochondrial Changes in β(0)-Thalassemia/Hb E Disease
por: Khungwanmaythawee, Kornpat, et al.
Publicado: (2016)

Very mild forms of Hb S/beta(+)-thalassemia in Brazilian children
por: Belisário, André Rolim, et al.
Publicado: (2015)

P1465: INITIAL SAFETY AND EFFICACY STUDY OF RM-001, AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS, IN TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
por: Wang, L., et al.
Publicado: (2022)

S272: SAFETY AND EFFICACY OF RM-001 IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA: EARLY RESULTS FROM THE ONGOING OF AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS
por: Liu, Rongrong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r1bp0ct951rhjnr7v1o294qdn0